Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMBJ
4251
Embraer S.A. ADS
EMBJ
$12.2B
| $23.1K | ﹤0.01% |
+896
| New | +$24.3K |
|
4252
ProShares UltraShort S&P500
SDS
$415M
| $23K | ﹤0.01% |
200
| – | – |
|
|
RDNW
4253
RideNow Group
RDNW
$238M
| $23K | ﹤0.01% |
+5,618
| New | +$30.8K |
|
4254
Freedom Holding
FRHC
$9.63B
| $22.9K | ﹤0.01% |
304
-12,565
| -98% | -$911K |
|
4255
Microvast
MVST
$269M
| $22.9K | ﹤0.01% |
50,188
-104,975
| -68% | -$47.1K |
|
4256
Cue Biopharma
CUE
$113M
| $22.7K | ﹤0.01% |
610
-437
| -42% | -$21.6K |
|
4257
Tower Semiconductor
TSEM
$24.8B
| $22.5K | ﹤0.01% |
573
-14,478
| -96% | -$514K |
|
4258
Citius Pharmaceuticals
CTXR
$15.6M
| $22.1K | ﹤0.01% |
1,513
-2,266
| -60% | -$40.6K |
|
|
AKYA
4259
DELISTED
Akoya BioSciences
AKYA
| $21.9K | ﹤0.01% |
9,377
-8,551
| -48% | -$27.3K |
|
|
CLCO
4260
DELISTED
Cool Company
CLCO
| $21.7K | ﹤0.01% |
1,840
-17,138
| -90% | -$197K |
|
4261
Alliance Resource Partners
ARLP
$3.34B
| $21.5K | ﹤0.01% |
881
-1,905
| -68% | -$43.2K |
|
4262
Urban One Class A
UONE
$22.8M
| $21.4K | ﹤0.01% |
1,076
-4,607
| -81% | -$99.9K |
|
4263
CALL
MacroGenics
MGNX
$235M
| $21.3K | ﹤0.01% |
+5,000
| New | +$48.7K |
|
4264
Sasol
SSL
$7.5B
| $21.2K | ﹤0.01% |
+2,785
| New | +$20.6K |
|
4265
Valaris Ltd Warrants
VAL.WS
$684M
| $21.2K | ﹤0.01% |
1,616
| – | – |
|
4266
Purple Innovation
PRPL
$35.3M
| $20.3K | ﹤0.01% |
781
-742
| -49% | -$26.1K |
|
4267
Identive
INVE
$63.4M
| $20K | ﹤0.01% |
4,662
-26,513
| -85% | -$126K |
|
|
AEVA
4268
Aeva Technologies
AEVA
$1.2B
| $20K | ﹤0.01% |
7,946
-3,332
| -30% | -$10.9K |
|
|
KRON
4269
DELISTED
Kronos Bio
KRON
| $20K | ﹤0.01% |
16,128
| – | – |
|
4270
GeoPark
GPRK
$633M
| $20K | ﹤0.01% |
1,823
-593
| -25% | -$5.94K |
|
4271
Outlook Therapeutics
OTLK
$183M
| $19.9K | ﹤0.01% |
2,694
-2,802
| -51% | -$22.5K |
|
|
FIRY
4272
Firy Inc
FIRY
$148M
| $19.9K | ﹤0.01% |
2,769
| – | – |
|
4273
Southland Holdings
SLND
$30.2M
| $19.9K | ﹤0.01% |
4,339
+891
| +26% | +$4.39K |
|
4274
ProShares Ultra QQQ
QLD
$12.7B
| $19.9K | ﹤0.01% |
398
-700
| -64% | -$31.1K |
|
|
EDN
4275
Edenor
EDN
$1.17B
| $19.7K | ﹤0.01% |
+1,200
| New | +$21.1K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.